ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

FDBK Feedback Plc

130.00
-10.00 (-7.14%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Feedback Plc LSE:FDBK London Ordinary Share GB00BJN59X09 ORD 50P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -10.00 -7.14% 130.00 125.00 135.00 140.00 125.00 140.00 22,878 14:00:27
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Electronic Computers 1.03M -2.92M -0.2188 -5.94 17.34M

Feedback PLC Joint broker update (5643T)

06/07/2018 7:00am

UK Regulatory


Feedback (LSE:FDBK)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Feedback Charts.

TIDMFDBK

RNS Number : 5643T

Feedback PLC

06 July 2018

6 July 2018

Feedback plc

("Feedback" or the "Company")

Joint broker update

Feedback plc (AIM: FDBK), the specialist medical imaging technology company, announces that the Company's joint brokers are now solely Allenby Capital Limited and Peterhouse Corporate Finance Ltd.

For further information, please contact:

 
 Feedback plc                                      Tel: 01954 718072 
  David Crabb, Chief Executive Officer              IR@fbk.com 
  Lara Mott, Investor Relations 
 Allenby Capital Limited (Nominated Adviser and    Tel: 020 3328 5656 
  Joint Broker) 
  David Worlidge / Asha Chotai 
 Peterhouse Corporate Finance Ltd (Joint Broker) 
 Lucy Williams / Duncan Vasey                      Tel: 020 7469 093 
 

Notes to editors

About Feedback plc

Feedback plc is a specialist medical imaging technology company. It develops software and systems that provide innovative techniques and improved workflows for practitioners involved in medical research and treating patients. TexRAD(R) , the Company's patented quantitative image texture analysis technology, has the potential to assist clinicians in diagnosis, prognosis and treatment of patients with cancer and is currently installed in over 50 of the world's leading research institutions across Europe, North America, Asia and Australasia. The Cadran platform provides a suite of medical imaging tools for decision support. The Cadran range includes the picture archiving communication system (PACS) to provide decision support for scan analysis, diagnostic workstations which provide secure remote access to view scans on demand, and products to securely share and transport patient data. Visit www.fbk.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

MSCUSRWRWUABRRR

(END) Dow Jones Newswires

July 06, 2018 02:00 ET (06:00 GMT)

1 Year Feedback Chart

1 Year Feedback Chart

1 Month Feedback Chart

1 Month Feedback Chart

Your Recent History

Delayed Upgrade Clock